COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.
The international news story that broke at AIDS 2020, explained by the lead researcher.
An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.
Research showing housing as part of public health in HIV has long been established. But now, experts are also seeing the connection to COVID-19.
LaRon Nelson, Ph.D., RN, talks about public health’s responsibility to meet this extraordinary moment.
Hostilities against migrants and indigenous people are also threats to their health.
In addition to scientific advances, the 23rd International AIDS Conference also focused on the human rights of marginalized groups.
Joint Action and Service Integration Needed to Tackle HIV and TB During COVID-19 Pandemic, Experts Agree
Global health leaders warn that the pandemic may impact health systems and worsen the world's pre-existing epidemics.
A pair of presentations at AIDS 2020 provides some of the largest studies to date on COVID-19 among people with HIV, but leaves us with many questions about the interplay between the two viruses.
New data presented at AIDS 2020 show the long-acting injectable drug cabotegravir proved superior to daily oral TDF/FTC for MSM and transgender women.
People living with HIV in the U.S. are experiencing increases in body mass index at a rate three times greater than that of the general U.S. population, according to new research presented at AIDS 2020.